ABSTRACT
Resumo Estudo com objetivo de analisar, segundo a perspectiva de gestores e profissionais de saúde, as repercussões da pandemia por Covid-19 para os serviços de referência às hepatites virais no estado de Mato Grosso. Trata-se de pesquisa avaliativa, em abordagem descritiva de dados qualitativos, coletados por meio de entrevistas semiestruturada. A análise temática resultou em duas categorias: "Pandemia de Covid-19 e fragilidades na atenção às hepatites virais" e "Desafios da gestão na atenção às hepatites virais agravados pela pandemia". Constatou-se dificuldades de organização e implementação de estratégias para favorecer o cuidado, durante a pandemia, por ter redução no serviço administrativo na gestão estadual, ausência de diretrizes para os serviços e limitação no quantitativo de profissional, além da necessidade de remanejamento para atendimento a Covid-19. Os desafios postos pela gestão incluem a prioridade de ações estratégicas para aumentar a testagem e oportunizar acesso aos serviços de referência. Entretanto, a rotatividade de gestores e quantitativo de profissionais repercute no enfrentamento às hepatites. A organização da rede de atenção precisa avançar na governança das ações e serviços e em rearranjos organizacionais capazes de permitir respostas mais rápidas nos fluxos da atenção.
Abstract Study carried out with the objective of analyzing the repercussions of the Covid 19 pandemic on reference services for viral hepatitides in the state of Mato Grosso from the perspective of managers and health professionals. This is an evaluative research with a descriptive approach of qualitative data through semi-structured interviews. The thematic analysis resulted in two categories: "Covid-19 pandemic and weaknesses in viral hepatitis care" and "Management challenges in viral hepatitis care aggravated by the pandemic". The study found difficulties in organizing and implementing care strategies during the pandemic due to the reduction in the state administrative service, in addition to the absence of guidelines to perform the services and limitation in the number of professionals; also, due to the need for relocation to face the Covid 19 pandemic. Management challenges include prioritizing strategic actions in order to increase testing and provide access to reference services. The turnover of managers and the number of professionals have repercussions on coping with hepatitides. It is necessary to organize the care network with the objective of advancing actions and services that allow faster responses in care flows.
Subject(s)
Humans , Health Personnel , Health Management , Delivery of Health Care/organization & administration , Health Manager , COVID-19 , Hepatitis, Viral, Human/therapy , Brazil , Health Vulnerability , Health Services AccessibilityABSTRACT
Since the coronavirus disease pandemic response began in March 2020, tests, vaccinations, diagnoses, and treatment initiations for sexual health, HIV, and viral hepatitis in England have declined. The shift towards online and outreach services happened rapidly during 2020 and highlights the need to evaluate the effects of these strategies on health inequalities.
Subject(s)
COVID-19 , HIV Infections , Hepatitis, Viral, Human , Sexually Transmitted Diseases , England/epidemiology , HIV Infections/diagnosis , HIV Infections/epidemiology , Hepatitis, Viral, Human/epidemiology , Hepatitis, Viral, Human/therapy , Humans , Pandemics/prevention & control , SARS-CoV-2 , Sexually Transmitted Diseases/epidemiologySubject(s)
COVID-19 , Delivery of Health Care , HIV Infections , Hepatitis, Viral, Human , Vulnerable Populations , Blood-Borne Infections/epidemiology , Blood-Borne Infections/therapy , COVID-19/epidemiology , COVID-19/prevention & control , Communicable Disease Control/organization & administration , Delivery of Health Care/methods , Delivery of Health Care/organization & administration , Delivery of Health Care/trends , Drug Users , HIV Infections/epidemiology , HIV Infections/therapy , Health Services Needs and Demand , Hepatitis, Viral, Human/epidemiology , Hepatitis, Viral, Human/therapy , Ill-Housed Persons , Humans , Prisoners , SARS-CoV-2 , United Kingdom/epidemiologySubject(s)
Communicable Disease Control , Coronavirus Infections , Delivery of Health Care , Gastroenterology , Hepatitis, Viral, Human , Pandemics , Pneumonia, Viral , Africa South of the Sahara/epidemiology , Betacoronavirus , COVID-19 , Communicable Disease Control/methods , Communicable Disease Control/organization & administration , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Delivery of Health Care/methods , Delivery of Health Care/statistics & numerical data , Delivery of Health Care/trends , Gastroenterology/methods , Gastroenterology/statistics & numerical data , Health Services/statistics & numerical data , Health Services Needs and Demand , Hepatitis, Viral, Human/epidemiology , Hepatitis, Viral, Human/therapy , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2ABSTRACT
In December 2019, a novel coronavirus was identified in patients in Wuhan, China. The virus, subsequently named severe acute respiratory syndrome coronavirus-2, spread worldwide and the disease (coronavirus disease 2019 or COVID-19) was declared a global pandemic by the World Health Organization in March 2020. Older adults and individuals with comorbidities have been reported as being more vulnerable to COVID-19. Patients with chronic liver disease (CLD) have compromised immune function due to cirrhosis and are more susceptible to infection. However, it is unclear if patients with CLD are more vulnerable to COVID-19 and its complications than other populations. The high number of severe cases of COVID-19 has placed an unusual burden on health systems, compromising their capacity to provide the regular care that patients with CLD require. Hence, it is incredibly crucial at this juncture to provide a set of interim recommendations on the management of patients with CLD during the current COVID-19 outbreak.